Magnesium for the postoperative analgesia of DM feet amputation

Magnesium sulphate is used for perioperative analgesia

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14004944

Enrollment

Unknown

Registered

2014-07-11

Start date

2014-07-15

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DM feet amputation

Interventions

1:0.25% ropivacaine 15ml

2:0.25% ropivacaine 15ml and 200mg MgSO4

3:0.375% ropivacaine 15ml

Eligibility

Sex/Gender

All

Age

50 Years to 80 Years

Inclusion criteria

Inclusion criteria: DM feet patients perform amputation surgery

Exclusion criteria

Exclusion criteria: Deaf, blind; psychological disorder; sedative abuse; opioid abuse; alcohol abuse; congestive heart failure; EF less than 30%; expected survival period shorter than 6 months; stroke within 12 months; severe bleeding within 12 months; allergic to lidocaine or sulphate.

Design outcomes

Primary

Measure	Time frame
postoperative VAS pain score;postoperative rescue analgesia time;	—

Secondary

Measure	Time frame
postoperative 24h of b-endophine;	—

Countries

China

Contacts

Public ContactJiehao Sun

1st Affiliated Hospital of Wenzhou Medical University

sun_jiehao@126.com+86 13676721930

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026